Related Experiment Video
Updated: Jun 23, 2026
07:23
Surgery and Behavioral Testing in the Tibial Neuroma Transposition Model in Rats
Published on: January 7, 2023
Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis
Hyunmi Choi1, Randall L Sell, Leslie Lenert
1Department of Neurology, Columbia University, New York, NY, USA. hc323@columbia.edu
JAMA
|December 4, 2008
Summary
Anterior temporal lobe resection significantly improves survival and quality of life for epilepsy patients compared to continued medical management. Surgery offers substantial gains in life expectancy and reduced mortality for eligible individuals.
Area of Science:
- Neurosurgery
- Epileptology
- Health Economics
Background:
- Patients with pharmacoresistant epilepsy face higher mortality rates than the general population.
- Anterior temporal lobe resection (ATLR) in surgically eligible patients with pharmacoresistant temporal lobe epilepsy (PTLE) who achieve seizure freedom reduces excess mortality.
- Continued medical management for PTLE is associated with persistent seizures and elevated mortality risks.
Purpose of the Study:
- To quantify the survival benefit of ATLR versus ongoing medical management for patients with PTLE.
- To assess the impact of ATLR on quality-adjusted life expectancy in surgically eligible PTLE patients.
Main Methods:
- A Monte Carlo simulation model was developed, incorporating surgical complications and seizure status over 10,000 runs.
- The model utilized patient-reported quality-of-life data and existing medical literature.
- Life expectancy and quality-adjusted life expectancy were the primary outcome measures.
Main Results:
- For a 35-year-old patient, ATLR is projected to increase survival by 5.0 years compared to medical management.
- ATLR is estimated to improve quality-adjusted life expectancy by 7.5 quality-adjusted life-years.
- Surgery was preferred in 96.5%–100% of simulations, driven by reduced seizure burden and improved quality of life.
Conclusions:
- Decision analysis indicates ATLR offers significant improvements in life expectancy for surgically eligible PTLE patients.
- ATLR provides substantial gains in quality-adjusted life expectancy compared to continued medical treatment.
- The findings support ATLR as a beneficial intervention for selected patients with pharmacoresistant temporal lobe epilepsy.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.